Products Abemaciclib was approved in the form of film-coated tablets in the United States in 2017, in the EU in 2018, and in many countries in 2019 (Verzenios). Structure and properties Abemaciclib (C27H32F2N8, Mr = 506.6 g/mol) exists as a white to yellow powder. Effects Abemaciclib (ATC L01XE50) has antitumor and antiproliferative properties. The effects … Abemaciclib
Products Palbociclib was approved in capsule form in the United States in 2015, in the EU in 2016, and in many countries in 2017 (Ibrance). Structure and properties Palbociclib (C24H29N7O2, Mr = 447.5 g/mol) is a pyridopyrimidine and exists as a yellow to orange powder. Effects Palbociclib (ATC L01XE33) has antitumor and antiproliferative properties. The … Palbociclib
Products Ribociclib was approved in the United States, the EU, and many countries in 2017 in film-coated tablet form (Kisqali). Structure and properties Ribociclib (C23H30N8O, Mr = 434.5 g/mol) is present in the drug as ribociclibsuccinate, a pale yellow to yellow-brown crystalline powder. Effects Ribociclib (ATC L01XE42) has antitumor and antiproliferative properties. The effects are … Ribociclib
